Abstract
The controversial black-box warning for antidepressants describing the possible link between use of these drugs and suicide in adolescents has sparked an active debate regarding the appropriate treatment of depression in younger patients. The warning, required in the labeling of at least 32 commonly prescribed antidepressants, not only focuses attention on concerns about these medications for pediatric patients but also highlights a widening gap between the needs of the approximately 2.7 million US children and adolescents with significant depression and the nation's relatively small number of trained child psychiatrists. However, a growing recognition of this unmet need is driving new efforts to address the problem. Primary care pediatricians, family medicine practitioners, and psychiatrists are collaborating to formulate and promote guidelines and other measures.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
